Article
Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial
2022-08-03
Abstract excerpt
<h4>Background</h4> Children with sickle cell anemia in areas of Africa with endemic malaria transmission are commonly prescribed malaria chemoprevention. The comparative efficacy of prevention regimens is largely unknown. <h4>Methods and Findings</h4> We enrolled Kenyan children aged 1-10 years with HbSS in a randomized, open-label trial conducted between January 23, 2018, and December 15, 2020, in Homa Bay, Keny...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1548b46a-feba-5d95-ac51-9ba0b4a5b668
- DOI
- 10.1101/2022.08.02.22278335
